Metabolism
Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
-
A4302 Rosiglitazone maleateTarget: Insulin and Insulin-like ReceptorsSummary: PPARγ agonist,high-affinity and selective,potent insulin sensitizer
-
A4324 Pioglitazone HClSummary: PPARγ agonist
-
B1943 Fenofibrate1 CitationSummary: PPARα agonist
-
A8333 Canagliflozin1 CitationTarget: SGLTSummary: SGLT2 inhibitor,potent and selective
-
B7794 BMS 3094032 CitationTarget: Fatty-acid-binding proteins (FABPs)Summary: FABP4 inhibitor,potent and selective